Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
Osann IP Consulting Announces Their Electronic Mirror Patent to Be Sold at ICAP Fall 2011 Live IP Auction Osann IP Consulting and Mary M. Fasching today announced the auction of their Electronic Mirror patent portfolio at the ICAP Patent Brokerage Fall 2011 Live IP Auction on November 17th in San Francisco.
more
Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).
more
Reality Mobile® Awarded Additional Patent in Area of Mobile Peer-to-Peer Communications Reality Mobile®, a Virginia-based technology company delivering enterprise-class real-time mobile video collaboration solutions, today announced that the United States Patent and Trademark Office has granted another industry-defining patent (U.S. Patent No. 8,041,829) to the company in the area of mobile, peer-to-peer communications.
more
